Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001640334-25-001281
Filing Date
2025-07-23
Accepted
2025-07-23 14:31:12
Documents
36
Period of Report
2024-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q acbm_10q.htm   iXBRL 10-Q 502645
2 CERTIFICATION acbm_ex311.htm EX-31.1 9535
3 CERTIFICATION acbm_ex321.htm EX-32.1 4057
  Complete submission text file 0001640334-25-001281.txt   1817408

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA acro-20240930.xsd EX-101.SCH 16826
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE acro-20240930_lab.xml EX-101.LAB 113320
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE acro-20240930_cal.xml EX-101.CAL 25381
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE acro-20240930_pre.xml EX-101.PRE 84399
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE acro-20240930_def.xml EX-101.DEF 24138
39 EXTRACTED XBRL INSTANCE DOCUMENT acbm_10q_htm.xml XML 168821
Mailing Address 12175 VISIONARY WAY SUITE 1160 FISHERS IN 46038
Business Address 12175 VISIONARY WAY SUITE 1160 FISHERS IN 46038 (317) 286-6788
ACRO BIOMEDICAL CO., LTD. (Filer) CIK: 0001622996 (see all company filings)

EIN.: 471950356 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-55643 | Film No.: 251142754
SIC: 7900 Services-Amusement & Recreation Services
(CF Office: 07 Trade & Services)